Trademark Overview
On Tuesday, February 6, 2024, a trademark application was filed for XORBECY with the United States Patent and Trademark Office. The USPTO has given the XORBECY trademark a serial number of 98394866. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, November 5, 2024. This trademark is owned by Pfizer Inc.. The XORBECY trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; Pharmaceutical preparations for the treatment of sickle cell disease; pharmaceutical preparations for the treatment of hypoxic and hypoxemic conditions
